Catalysts for $1B MC?, page-52

I think you got her there mate....this would be a major scandal.  Here's all some proof for disqualification for listing.  Everyone sell!

<< First< Prev

Page of 614

Next >Last >>

Select item 268587711.

The antiviral compound BIT225 inhibits HIV-1 replication in myeloid dendritic cells.

Khoury G, Ewart G, Luscombe C, Miller M, Wilkinson J.

AIDS Res Ther. 2016 Feb 8;13:7. doi: 10.1186/s12981-016-0093-z. eCollection 2016.

PMID:

26858771

Free PMC Article

Similar articles

Select item 201564862.

A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-alpha-2b and nucleoside analogues.

Luscombe CA, Huang Z, Murray MG, Miller M, Wilkinson J, Ewart GD.

Antiviral Res. 2010 May;86(2):144-53. doi: 10.1016/j.antiviral.2010.02.312. Epub 2010 Feb 13.

PMID:

20156486

Similar articles

Select item 266201013.

A Phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infection.

Wilkinson J, Ewart G, Luscombe C, McBride K, Ratanasuwan W, Miller M, Murphy RL.

J Antimicrob Chemother. 2016 Mar;71(3):731-8. doi: 10.1093/jac/dkv389. Epub 2015 Nov 29.

PMID:

26620101

Similar articles

Select item 199959244.

Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages.

Khoury G, Ewart G, Luscombe C, Miller M, Wilkinson J.

Antimicrob Agents Chemother. 2010 Feb;54(2):835-45. doi: 10.1128/AAC.01308-09. Epub 2009 Dec 7.

PMID:

19995924

Free PMC Article

Similar articles